2-tert-butylhydroquinone has been researched along with rifampin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baus, PR; Ermel, N; Kauffmann, HM; Klein, C; Schrenk, D; Vorderstemann, B | 1 |
Benz, A; Kauffmann, HM; Pfannschmidt, S; Schrenk, D; Vorderstemann, B; Webster, JI; Zöller, H | 1 |
Auld, DS; Austin, CP; Huang, R; Moeller, TA; Sakamuru, S; Shinn, P; Shukla, SJ; Vanleer, D; Xia, M | 1 |
3 other study(ies) available for 2-tert-butylhydroquinone and rifampin
Article | Year |
---|---|
Up-regulation of transporters of the MRP family by drugs and toxins.
Topics: Animals; Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Carrier Proteins; Gene Expression Regulation; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Toxins, Biological; Up-Regulation | 2001 |
Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression.
Topics: Arsenites; Cell Line; Clotrimazole; DNA-Binding Proteins; Gene Expression Regulation; Genes, Reporter; Humans; Hydroquinones; Mitochondrial Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; MutS Homolog 3 Protein; Oxidation-Reduction; Pregnane X Receptor; Quercetin; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Ribosomal Proteins; Rifampin; RNA, Messenger; Saccharomyces cerevisiae Proteins | 2002 |
Identification of clinically used drugs that activate pregnane X receptors.
Topics: Animals; Cell Line, Tumor; Cytochrome P-450 CYP3A; Drug Interactions; Hep G2 Cells; Hepatocytes; Humans; Pharmaceutical Preparations; Pregnane X Receptor; Rats; Receptors, Steroid; Small Molecule Libraries; Species Specificity; Structure-Activity Relationship; Xenobiotics | 2011 |